Effect of Liraglutide on Blood Pressure: a Meta-Analysis of Liraglutide Randomized Controlled Trials
48-week outcomes were the key secondary [3]
Early findings suggest that tirzepatide may not only aid in weight loss and blood sugar control but also contribute to improved heart health, which is particularly important for individuals with type 2 diabetes who are at a higher risk for cardiovascular diseases
Whatever brings you here, we're ready to meet your needs, coordinate with your primary care or specialists, to ensure continuous, coordinated care
Introduction Over a decade ago, the first injectable glucagon-like peptide-1 receptor agonist (GLP-1) for type 2 diabetes mellitus (T2DM) was approved by the Food and Drug Administration (FDA) for chronic weight management
Dizziness risk may be higher at greater doses and during dose escalation periods